Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Breast Neoplasms 3Neoplasms 2Fatigue 2Weight Loss 1Systemic carnitine deficiency 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Pain 1Neurotoxicity Syndromes 1Muscular Atrophy 1Muscle Weakness 1Motor Activity 1Malnutrition 1Leukemia, Biphenotypic, Acute 1Insulin Resistance 1Hyperbilirubinemia 1Hyperandrogenism 1Hirsutism 1Heart Failure 1Gastrointestinal Stromal Tumors 1Dyslipidemias 1Depression 1Cardiotoxicity 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1Cachexia 1Burkitt Lymphoma 1Basal Cell Nevus Syndrome 1

Interventions

Carnitine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Systemic carnitine deficiency × Carnitine × Clear all
NCT00091169 2023-07-05

Levocarnitine in Treating Fatigue in Cancer Patients

Eastern Cooperative Oncology Group

Phase 3 Completed
376 enrolled 11 charts

Systemic carnitine deficiency, Depression, Fatigue, Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡